International journal of infectious diseases, 2016-08, Vol.49 (C), p.151-153
2016
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Daclatasvir plasma level and resistance selection in HIV patients with hepatitis C virus cirrhosis treated with daclatasvir, sofosbuvir, and ribavirin
- Ist Teil von
- International journal of infectious diseases, 2016-08, Vol.49 (C), p.151-153
- Ort / Verlag
- Canada: Elsevier Ltd
- Erscheinungsjahr
- 2016
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Highlights • Low daclatasvir levels allowed the selection of resistance-associated variants. • Quantitation of daclatasvir levels in HIV–hepatitis C virus (HCV) cirrhotic patients on highly active antiretroviral therapy is suggested. • Resistance testing is suggested even at low HCV RNA levels.
- Sprache
- Englisch
- Identifikatoren
- ISSN: 1201-9712eISSN: 1878-3511DOI: 10.1016/j.ijid.2016.06.020Titel-ID: cdi_doaj_primary_oai_doaj_org_article_ea33f99ee10f488ea077ed968f904102
- Format
- –
- Schlagworte
- Antiviral Agents - administration & dosage, Coinfection - drug therapy, Daclatasvir, Drug Resistance, Viral, Drug Therapy, Combination, Female, Hepatitis C - drug therapy, HIV Infections - drug therapy, HIV–HCV patients, Humans, Imidazoles - administration & dosage, Imidazoles - blood, Infectious Disease, Liver Cirrhosis - etiology, Male, Middle Aged, Mutation, Population-based sequencing, Pulmonary/Respiratory, Ribavirin - administration & dosage, Sofosbuvir - administration & dosage, Therapeutic drug monitoring, Virological failure